M. Biagioli

Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases

Anna Maria Di Giacomo, Riccardo Danielli, Massimo Guidoboni et al. · Cancer Immunology Immunotherapy · 2009 · 272 citations · Full text

Systemic Treatments, Tumor Immunology, Medicine +9

Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions

Clelia Miracco, Gabriele Cevenini, Alessandro Franchi et al. · Human Pathology · 2009 · 139 citations

Autoimmune Disease, Cutaneous Biology, Melanoma +10

Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme

Anna Maria Di Giacomo, Luana Calabrò, Riccardo Danielli et al. · Cancer Immunology Immunotherapy · 2013 · 134 citations · Full text

Expanded Access Programme, Oncology, Skin Cancer +9

Digital dermoscopy analysis for the differentiation of atypical nevi and early melanoma: a new quantitative semiology.

Lucio Andreassi, Roberto Perotti, Pietro Rubegni et al. · PubMed · 1999 · 132 citations

Utility of tumour-infiltrating CD25+FOXP3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma

Vasileios Mourmouras, M. Biagioli, Clelia Miracco et al. · Oncology Reports · 2007 · 91 citations · Full text